0 followers
OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing... Read more
Mitchel Sivilotti
This company has no teams yet
Kura Oncology
20 followers
Dyne Therapeutics
3 followers
Precigen
3 followers
Arcturus Therapeutics
2 followers
Biocytogen
2 followers
Gamida Cell
2 followers
Fortis Life Sciences
1 follower
Entrada Therapeutics
1 follower
Cabaletta Bio
1 follower
Janux Therapeutics
1 follower
Matica Biotechnology
1 follower
Explore companies